MP14-16 COMBINATION THERAPY FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

2020 
INTRODUCTION AND OBJECTIVE:The combination of immune checkpoint inhibitors and antiangiogenics have emerged as a new treatment modality for metastatic renal cell carcinoma (mRCC). Recent randomized...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []